Recently, Abbott announced that the FlexAbility ablation catheter matching the sensor has been approved by the US FDA to improve the versatility and precision of cardiac ablation surgery for atrial flutter (a type of irregular heartbeat). After this approval, the company has further expanded its electrophysiological portfolio to benefit patients with abnormal heart rhythms (arrhythmia).
Ablation catheters are used to help treat patients with irregular heartbeats, which are medically known as arrhythmias. Arrhythmias can cause symptoms such as palpitations and dizziness, and even cause stroke or cardiac arrest. During an ablation procedure, the catheter delivers energy to the heart tissue, creating a small area of ​​scarring or damage to the area responsible for the arrhythmia. The purpose of mediating these injuries is to prevent abnormal electrical signals from entering the heart, which is expected to restore the heart to rhythm.
This sensor-matched FlexAbility ablation catheter is Abbott's first ablation catheter product that collects current resistance (impedance) and permeability data for detailed and accurate mapping, helping to trigger or maintain abnormal heart rhythm treatment . It is also ABB's second Enabled Sensor tool in the United States, inheriting the company's EnSite Precision cardiac mapping system, which also includes sensor-matched Advisor FL ring mapping catheter products.
When used with the EnSite Precision cardiac mapping system, the sensor-matched catheter allows the physician to create a highly detailed 3-dimensional heart model that overlays the electrophysiological activity of the heart. These models help doctors identify the type of arrhythmia and the area they should treat with an ablation catheter. The catheter is also compatible with Abbott's MediGuide technology, allowing doctors to reduce the duration of actual X-rays during surgery.
Molecular Diagnostics POCT, POCT Detection System
HANGZHOU DIAN BIOTECHNOLOGY CO., LTD. , https://www.dianbiotech.com